media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Jenburkt Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]136.14123.73108.87118.04122.05
Other Operating Revenues0.610.250.430.850.59
Total Operating Revenues136.75123.98109.29118.89122.64
      
Other Income5.124.954.314.223.41
Total Revenue141.87128.93113.60123.11126.05
      
EXPENSES     
Cost Of Materials Consumed11.1211.746.789.6511.84
Purchase Of Stock-In Trade20.5521.9820.1323.9026.91
Operating And Direct Expenses0.800.630.340.520.80
Changes In Inventories Of FG,WIP And Stock-In Trade1.34-2.283.18-0.49-2.49
Employee Benefit Expenses38.8136.4932.3836.5131.20
Finance Costs0.370.430.470.530.39
Depreciation And Amortisation Expenses2.261.902.042.301.35
Other Expenses33.7728.1726.6329.0529.42
Total Expenses109.0199.0691.96101.9799.42
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax32.8629.8721.6421.1426.63
      
Profit/Loss Before Tax32.8629.8721.6421.1426.63
      
Tax Expenses-Continued Operations     
Current Tax8.567.355.455.767.52
Deferred Tax-0.230.30-0.390.37-0.31
Tax For Earlier Years-0.08-0.070.090.14-0.38
Total Tax Expenses8.267.575.146.276.84
Profit/Loss After Tax And Before ExtraOrdinary Items24.6122.3016.5014.8719.80
      
Profit/Loss From Continuing Operations24.6122.3016.5014.8719.80
      
Profit/Loss For The Period24.6122.3016.5014.8719.80
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)53.9048.5835.9632.4043.14
Diluted EPS (Rs.)53.9048.5835.9632.4043.14
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend5.514.680.0010.123.32
Equity Dividend Rate (%)144.00120.00102.0081.00102.00
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]136.14
Other Operating Revenues0.61
Total Operating Revenues136.75
Other Income5.12
Total Revenue141.87
EXPENSES 
Cost Of Materials Consumed11.12
Purchase Of Stock-In Trade20.55
Operating And Direct Expenses0.80
Changes In Inventories Of FG,WIP And Stock-In Trade1.34
Employee Benefit Expenses38.81
Finance Costs0.37
Depreciation And Amortisation Expenses2.26
Other Expenses33.77
Total Expenses109.01
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax32.86
Profit/Loss Before Tax32.86
Tax Expenses-Continued Operations 
Current Tax8.56
Deferred Tax-0.23
Tax For Earlier Years-0.08
Total Tax Expenses8.26
Profit/Loss After Tax And Before ExtraOrdinary Items24.61
Profit/Loss From Continuing Operations24.61
Profit/Loss For The Period24.61
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)53.90
Diluted EPS (Rs.)53.90
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend5.51
Equity Dividend Rate (%)144.00